Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H Activation Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111270260B reveals a green Rh-catalyzed C-H activation route using electricity, offering cost-effective API intermediate manufacturing without external oxidants.
Patent CN1256319C details a thionyl chloride method for L-β-asparagine. Achieves higher yields and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN111533684B reveals a novel quaternary ammonium activation strategy for pyridine alkenylation, offering high yields and simplified synthesis for reliable API intermediate manufacturing.
Patent CN104254538A reveals stable boronated derivatives enabling scalable Suzuki coupling for high-performance organic semiconductor materials and display applications.
Advanced synthesis of chiral bis[N,O] cyclopalladium complexes via patent CN108658802A. Offers high yield, cost reduction, and scalable manufacturing for fine chemical intermediates.
Patent CN114957170A reveals a cost-effective copper-catalyzed monofluoroolefination method offering superior Z-selectivity for reliable pharmaceutical intermediate manufacturing.
Patent CN109734644B reveals a novel Zirconium-catalyzed C7 alkylation method for indole derivatives, offering cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN111270260A introduces a green electrochemical Rh-catalyzed alkenylation method, offering cost reduction and scalable solutions for fine chemical manufacturing.
Patent CN112625020B details a novel Rh-catalyzed C-H activation route for isocoumarin derivatives, offering improved atom economy and supply chain reliability for pharmaceutical intermediates.
Novel Pd-catalyzed C-H activation method for 3-ester indoles. High yield ≥95%wt. Cost-effective scalable process for pharmaceutical intermediates.
Patent CN106632086B details a Rhodium-catalyzed C-H iodination method for quinazolines. This process offers high purity, mild conditions, and significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110698507A details a ligand-free Pd-catalyzed C-H alkenylation method for aryl vinyl silanes, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113461681A reveals efficient iridium-catalyzed C-H amination using ionic liquids, offering high purity pharmaceutical intermediates with reduced processing costs.
Patent CN108640945B reveals a novel Ru/Ir-catalyzed direct C-H alkynylation of amides. This method eliminates directing groups, offering cost-effective routes for high-purity pharmaceutical intermediates.
Patent CN109678911B details a high-efficiency Rh-catalyzed method for planar chiral ferrocene intermediates, offering superior enantioselectivity and supply chain reliability.
Novel U-shaped template strategy for meta-C-H olefination. Reduces steps and costs for API intermediates. High purity and scalability for pharmaceutical manufacturing.
Novel Rh-catalyzed C-H activation method for high-purity axial chiral intermediates with superior enantioselectivity and scalable process efficiency.
Novel C-H activation method for spiro quinazolinones offers high yield and scalability for reliable pharmaceutical intermediate supply chains.
Patent CN111217847B reveals novel thiosilane ligands enabling high-yield aryl boronation with superior purification and industrial scalability for pharma intermediates.
Patent CN113735756A details a high-yield Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.